Reder Nicholas P, Davis Christopher S, Kovacs Elizabeth J, Fisichella P Marco
Swallowing Center, Department of Surgery, Loyola University Medical Center, 2160 South 1st Avenue, Maywood, IL, 60153, USA.
Surg Endosc. 2014 Jun;28(6):1794-800. doi: 10.1007/s00464-013-3388-3. Epub 2014 Jan 11.
Gastroesophageal reflux disease (GERD) is thought to lead to aspiration and bronchiolitis obliterans syndrome after lung transplantation. Unfortunately, the identification of patients with GERD who aspirate still lacks clear diagnostic indicators. The authors hypothesized that symptoms of GERD and detection of pepsin and bile acids in the bronchoalveolar lavage fluid (BAL) and exhaled breath condensate (EBC) are effective for identifying lung transplantation patients with GERD-induced aspiration.
From November 2009 to November 2010, 85 lung transplantation patients undergoing surveillance bronchoscopy were prospectively enrolled. For these patients, self-reported symptoms of GERD were correlated with levels of pepsin and bile acids in BAL and EBC and with GERD status assessed by 24-h pH monitoring. The sensitivity and specificity of pepsin and bile acids in BAL and EBC also were compared with the presence of GERD in 24-h pH monitoring.
The typical symptoms of GERD (heartburn and regurgitation) had modest sensitivity and specificity for detecting GERD and aspiration. The atypical symptoms of GERD (aspiration and bronchitis) showed better identification of aspiration as measured by detection of pepsin and bile acids in BAL. The sensitivity and specificity of pepsin in BAL compared with GERD by 24-h pH monitoring were respectively 60 and 45 %, whereas the sensitivity and specificity of bile acids in BAL were 67 and 80 %.
These data indicate that the measurement of pepsin and bile acids in BAL can provide additional data for identifying lung transplantation patients at risk for GERD-induced aspiration compared with symptoms or 24-h pH monitoring alone. These results support a diagnostic role for detecting markers of aspiration in BAL, but this must be validated in larger studies.
胃食管反流病(GERD)被认为会导致肺移植后出现误吸和闭塞性细支气管炎综合征。遗憾的是,对于存在误吸的GERD患者的识别仍缺乏明确的诊断指标。作者推测,GERD症状以及支气管肺泡灌洗液(BAL)和呼出气冷凝液(EBC)中胃蛋白酶和胆汁酸的检测对于识别GERD所致误吸的肺移植患者是有效的。
2009年11月至2010年11月,前瞻性纳入85例行监测支气管镜检查的肺移植患者。对于这些患者,将自我报告的GERD症状与BAL和EBC中胃蛋白酶和胆汁酸的水平以及通过24小时pH监测评估的GERD状态进行关联分析。还将BAL和EBC中胃蛋白酶和胆汁酸的敏感性和特异性与24小时pH监测中GERD的存在情况进行比较。
GERD的典型症状(烧心和反流)在检测GERD和误吸方面的敏感性和特异性一般。GERD的非典型症状(误吸和支气管炎)在通过检测BAL中的胃蛋白酶和胆汁酸来衡量误吸方面显示出更好的识别能力。与24小时pH监测诊断的GERD相比,BAL中胃蛋白酶的敏感性和特异性分别为60%和45%,而BAL中胆汁酸的敏感性和特异性分别为67%和80%。
这些数据表明,与单独的症状或24小时pH监测相比,检测BAL中的胃蛋白酶和胆汁酸可为识别有GERD所致误吸风险的肺移植患者提供额外的数据。这些结果支持检测BAL中误吸标志物的诊断作用,但这必须在更大规模的研究中得到验证。